Coccidioidomycosis: A review and update

Journal of the American Academy of Dermatology

Volumn 55, Issue 6, 2006, Pages 929-942

  DiCaudo, David J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; ETANERCEPT; FLUCONAZOLE; INFLIXIMAB; ITRACONAZOLE; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PROTOZOON ANTIBODY; PYRROLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ARGENTINA; ARTHRITIS; BIOLOGICAL WARFARE; CELLULAR IMMUNITY; CLIMATE; CLINICAL FEATURE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; COMORBIDITY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIC; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; HEREDITY; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; IN SITU HYBRIDIZATION; INCIDENCE; INFECTION RISK; LUNG INFECTION; MENINGITIS; MICROSCOPY; PARASITE IDENTIFICATION; PRIORITY JOURNAL; RASH; REVIEW; SKIN BIOPSY; SKIN INFECTION; SKIN INFLAMMATION; SKIN MANIFESTATION; SKIN TEST; SOIL; TERATOGENICITY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UNITED STATES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIFUNGAL AGENTS; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DERMATOMYCOSES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNITY, CELLULAR; LUNG DISEASES, FUNGAL; MALE;

EID: 33750828695     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.039     Document Type: Review

References (180)

1. Posada A. Un nuevo caso de micosis fungoidea con psorospermias. An Circ Med Argent 15 (1892) 585-597
2. Ophuls W., and Moffitt H. A new pathogenic mould formerly described as a protozoan (Coccidioides immitis pyogenes): preliminary report. Philadelphia Med J5 (1900) 1471-1472
3. Smith C., Beard R., Whiting E., and Rosenberger H. Varieties of coccidiodal infection in relation to the epidemiology and control of the diseases. Am J Public Health 36 (1946) 1394-1402
4. Dickson E. "Valley fever" of the San Joaquin Valley and fungus Coccidioides. Calif West Med 47 (1937) 151-157
5. Galgiani J.N. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med 130 (1999) 293-300
6. Galgiani J.N., and Ampel N.M. Coccidioides immitis in patients with human immunodeficiency virus infections. Semin Respir Infect 5 (1990) 151-154
7. Galgiani J.N., and Ampel N.M. Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis 162 (1990) 1165-1169
8. Fish D.G., Ampel N.M., Galgiani J.N., Dols C.L., Kelly P.C., Johnson C.H., et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine 69 (1990) 384-391
9. Woods C.W., McRill C., Plikaytis B.D., Rosenstein N.E., Mosley D., Boyd D., et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 181 (2000) 1428-1434
10. Singh V.R., Smith D.K., Lawerence J., Kelly P.C., Thomas A.R., Spitz B., et al. Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clin Infect Dis 23 (1996) 563-568
11. Ampel N.M., Dols C.L., and Galgiani J.N. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 94 (1993) 235-240
12. Sarosi G.A., and Davies S.F. Endemic mycosis complicating human immunodeficiency virus infection. West J Med 164 (1996) 335-340
13. Ampel N.M. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART). Semin Respir Infect 16 (2001) 257-262
14. Jones J.L., Fleming P.L., Ciesielski C.A., Hu D.J., Kaplan J.E., and Ward J.W. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis 171 (1995) 961-966
15. Prichard J.G., Sorotzkin R.A., and James III R.E. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis 39 (1987) 203-205
16. Blair J.E., and Logan J.L. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 33 (2001) 1536-1544
17. Logan J.L., Blair J.E., and Galgiani J.N. Coccidioidomycosis complicating solid organ transplantation. Semin Respir Infect 16 (2001) 251-256
18. Cohen I.M., Galgiani J.N., Potter D., and Ogden D.A. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 142 (1982) 489-494
19. Schroter G.P., Bakshandeh K., Husberg B.S., and Well III R. Coccidioidomycosis and renal transplantation. Transplantation 23 (1977) 485-489
20. Hall K.A., Sethi G.K., Rosado L.J., Martinez J.D., Huston C.L., and Copeland J.G. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 12 (1993) 525-526
21. Holt C.D., Winston D.J., Kubak B., Imagawa D.K., Martin P., Goldstein L., et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 24 (1997) 216-221
22. Riley D.K., Galgiani J.N., O'Donnell M.R., Ito J.I., Beatty P.G., and Evans T.G. Coccidioidomycosis in bone marrow transplant recipients. Transplantation 56 (1993) 1531-1533
23. Murphey S.M., Drash A.L., and Donnelly W.M. Disseminated coccidioidomycosis associated with immunosuppressive therapy following renal transplantation. Pediatrics 48 (1971) 144-145
24. Crum N.F. Infections associated with tumor necrosis factor-[alpha] antagonists. Arthritis Rheum 84 (2005) 291-302
25. Bergstrom L., Yocum D.E., Ampel N.M., Villanueva I., Lisse J., Gluck O., et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum 50 (2004) 1959-1966
26. Dixon D.M. Coccidioides immitis as a Select Agent of bioterrorism. J Appl Microbiol 91 (2001) 602-605
27. Deresinski S. Coccidioides immitis as a potential bioweapon. Semin Respir Infect 18 (2003) 216-219
28. Stevens D.A. Coccidioidomycosis. New Engl J Med 332 (1995) 1077-1082
29. Possession, use, and transfer of select agents and toxins; interim final rule. Vol 42 C.F.R §73.4-73.5; 2002.
30. Burt A., Dechairo B.M., Koenig G.L., Carter D.A., White T.J., and Taylor J.W. Molecular markers reveal differentiation among isolates of Coccidioides immitis from California, Arizona and Texas. Mol Ecol 6 (1997) 781-786
31. Koufopanou V., Burt A., and Taylor J.W. Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis. Proc Natl Acad Sci U S A 94 (1997) 5478-5482
32. Fisher M.C., Rannala B., Chaturvedi V., and Taylor J.W. Disease surveillance in recombining pathogens: multilocus genotypes identify sources of human Coccidioides infections. Proc Natl Acad Sci U S A 99 (2002) 9067-9071
33. Fisher M.C., Koenig G.L., White T.J., and Taylor J.W. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 94 (2002) 73-84
34. Ampel N.M., and Christian L. In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis. Infect Immun 65 (1997) 4483-4487
35. Ampel N.M., and Christian L. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen. Med Mycol 38 (2000) 127-132
36. Ampel N.M., and Kramer L.A. In vitro modulation of cytokine production by lymphocytes in human coccidioidomycosis. Cell Immunol 221 (2003) 115-121
37. Cox R.A., and Magee D.M. Protective immunity in coccidioidomycosis. Res Immunol 149 (1998) 417-428
38. Cox R.A., and Vivas J.R. Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis. Cell Immunol 31 (1977) 130-141
39. Smith C.E., Saito M.T., and Simons S.A. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 160 (1956) 546-552
40. Smith C., Pappagianis D., Levine H., and Saito M. Human coccidioidomycosis. Bacteriol Rev 25 (1961) 310-320
41. Petkus A.F., and Baum L.L. Natural killer cell inhibition of young spherules and endospores of Coccidioides immitis. J Immunol 139 (1987) 3107-3111
42. Cox R.A., and Magee D.M. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev 17 (2004) 804-839
43. Chiller T.M., Galgiani J.N., and Stevens D.A. Coccidioidomycosis. Infect Dis Clin North Am 17 (2003) 41-57
44. Kolivras K.N., and Comrie A.C. Modeling valley fever (coccidioidomycosis) incidence on the basis of climate conditions. Int J Biometeorol 47 (2003) 87-101
45. Kirkland T.N., and Fierer J. Coccidioidomycosis: a reemerging infectious disease. Emerg Infect Dis 2 (1996) 192-199
46. Larwood T.R. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis 30 (2000) 612-613
47. Centers for Disease Control and Prevention. Coccidioidomycosis-Arizona, 1990-1995. MMWR Morb Mortal Wkly Rep 45 (1996) 1069-1073
48. Ampel N.M., Mosley D.G., England B., Vertz P.D., Komatsu K., and Hajjeh R.A. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 27 (1998) 1528-1530
49. Centers for Disease Control and Prevention. Increase in coccidioidomycosis-Arizona, 1998-2001. MMWR Morb Mortal Wkly Rep 52 (2003) 109-112
50. Arizona Department of Health Services. Bureau of Epidemiology and Disease Control Services. Rate per 100,000 population of reported cases of selected notifiable diseases by category, Arizona, 1994-2004. Available at: http://www.azdhs.gov/phs/oids/stats/pdf/Rates1994-2004.pdf. Accessed April 5, 2006.
51. Fisher M.C., Koenig G.L., White T.J., and Taylor J.W. Pathogenic clones versus environmentally driven population increase: analysis of an epidemic of the human fungal pathogen Coccidioides immitis. J Clin Microbiol 38 (2000) 807-813
52. Park B.J., Sigel K., Vaz V., Komatsu K., McRill C., Phelan M., et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis 191 (2005) 1981-1987
53. Comrie A.C. Climate factors influencing coccidioidomycosis seasonality and outbreaks. Environ Health Perspect 113 (2005) 688-692
54. Flynn N.M., Hoeprich P.D., Kawachi M.M., Lee K.K., Lawrence R.M., Goldstein E., et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med 301 (1979) 358-361
55. Schneider E., Hajjeh R.A., Spiegel R.A., Jibson R.W., Harp E.L., Marshall G.A., et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 277 (1997) 904-908
56. Centers for Disease Control and Prevention. Coccidioidomycosis following the Northridge Earthquake-California, 1994. MMWR Morb Mortal Wkly Rep 43 (1994) 194-195
57. Centers for Disease Control and Prevention. Coccidioidomycosis in workers at an archeologic site-Dinosaur National Monument, Utah, June-July 2001. MMWR Morb Mortal Wkly Rep 50 (2001) 1005-1008
58. Petersen L.R., Marshall S.L., Barton-Dickson C., Hajjeh R.A., Lindsley M.D., Warnok D.W., et al. Coccidioidomycosis among workers at an archeological site, northeastern Utah. Emerg Infect Dis 10 (2004) 637-642
59. Werner S.B., Pappagianis D., Heindl I., and Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 286 (1972) 507-512
60. Werner S.B., and Pappagianis D. Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff. Calif Med 119 (1973) 16-20
61. Crum N., Lamb C., Utz G., Amundson D., and Wallace M. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area-Coalinga, California. J Infect Dis 186 (2002) 865-868
62. Crum N.F., Lederman E.R., Hale B.R., Lim M.L., and Wallace M.R. A cluster of disseminated coccidioidomycosis cases at a US military hospital. Mil Med 168 (2003) 460-464
63. Goldstein D., and McDonald J. Primary pulmonary coccidioidomycosis. Follow-up of 75 cases, with 10 more cases from a new endemic area. JAMA 124 (1944) 557-561
64. Willett F.M., and Weiss A. Coccididioidomycosis in Southern California: report of a new endemic area with a review of 100 cases. Ann Int Med 23 (1945) 349-375
65. Olivere J.W., Meier P.A., Fraser S.L., Morrison W.B., Parsons T.W., and Drehner D.M. Coccidioidomycosis-the airborne assault continues: an unusual presentation with a review of the history, epidemiology, and military relevance. Aviat Space Environ Med 70 (1999) 790-796
66. Standaert S.M., Schaffner W., Galgiani J.N., Pinner R.W., Kaufman L., Durry E., et al. Coccidioidomycosis among visitors to a Coccidioides immitis-endemic area: an outbreak in a military reserve unit. J Infect Dis 171 (1995) 1672-1675
67. Panackal A.A., Hajjeh R.A., Cetron M.S., and Warnock D.W. Fungal infections among returning travelers. Clin Infect Dis 35 (2002) 1088-1095
68. Desai S.A., Minai O.A., Gordon S.M., O'Neil B., Wiedemann H.P., and Arroliga A.C. Coccidioidomycosis in non-endemic areas: a case series. Respir Med 95 (2001) 305-309
69. Chaturvedi V., Ramani R., Gromadzki S., Rodeghier B., Chang H.G., and Morse D.L. Coccidioidomycosis in New York State. Emerg Infect Dis 6 (2000) 25-29
70. Centers for Disease Control and Prevention. Coccidioidomycosis in travelers returning from Mexico-Pennsylvania. MMWR Morb Mortal Wkly Rep 49 (2000) 1004-1006
71. Cairns L., Blythe D., Kao A., Pappagianis D., Kaufman L., Kobayashi J., et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 30 (2000) 61-64
72. Long J.B., Brett A.S., and Horvath J.A. Coccidioidomycosis diagnosed in South Carolina. South Med J 98 (2005) 930-932
73. Einstein H.E., and Johnson R.H. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 16 (1993) 349-354
74. Crum N.F., Lederman E.R., Stafford C.M., Parrish J.S., Wallace M.R., Chang A., et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine 83 (2004) 149-175
75. Ampel N.M. Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area. Med Mycol 37 (1999) 245-250
76. Ampel N.M. Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis 2 (1996) 109-116
77. Antoniskis D., Larsen R.A., Akil B., Rarick M.U., and Leedom J.M. Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS 4 (1990) 691-693
78. Cockerell C.J. Cutaneous fungal infections in HIV/AIDS. J Int Assoc Physicians AIDS Care 1 (1995) 19-23
79. Johnson R.A. HIV disease: mucocutaneous fungal infections in HIV disease. Clin Dermatol 18 (2000) 411-422
80. Kappe R., Levitz S., Harrison T.S., Ruhnke M., Ampel N.M., and Just-Nubling G. Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection. Med Mycol 36 (1998) 207-215
81. McNeil M.M., and Ampel N.M. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 21 (1995) S111-S113
82. Calderon-Garciduenas A.L., Pina-Osuna K., Leal-Moreno A.M., Lopez-Cardenas A., and Cerda-Flores R.M. Caracteristicas clinicopatologicas y distribucion del numero de autopsias de pacientes fallecidos por coccidioidomicosis en un hospital de referencia del noreste de Mexico. Gac Med Mex 140 (2004) 399-404
83. Cha J.M., Jung S., Bahng H.S., Lim C.M., Han D.J., Woo J.H., et al. Multi-organ failure caused by reactivated coccidioidomycosis without dissemination in a patient with renal transplantation. Respirology 5 (2000) 87-90
84. Hall K.A., Copeland J.G., Zukoski C.F., Sethi G.K., and Galgiani J.N. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation 55 (1993) 1422-1424
85. Blair J.E., and Douglas D.D. Coccidioidomycosis in liver transplant recipients relocating to an endemic area. Dig Dis Sci 49 (2004) 1981-1985
86. Yorgin P.D., Rewari M., al-Uzri A.Y., Theodorou A.A., Scott K.M., and Barton L.L. Coccidioidomycosis in adolescents with lupus nephritis. Pediatr Nephrol 16 (2001) 77-81
87. Leake J.A., Mosley D.G., England B., Graham J.V., Plikaytis B.D., Ampel N.M., et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 181 (2000) 1435-1440
88. Deresinski S.C., and Stevens D.A. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital. Medicine 54 (1975) 377-395
89. Johnson W.M., and Gall E.P. Fatal coccidioidomycosis in collagen vascular diseases. J Rheumatol 10 (1983) 79-84
90. Rutala P.J., and Smith J.W. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci 275 (1978) 283-295
91. Kauffman C.A. Endemic mycoses in patients with hematologic malignancies. Semin Respir Infect 17 (2002) 106-112
92. Blair J.E., Smilack J.D., and Caples S.M. Coccidioidomycosis in patients with hematologic malignancies. Arch Int Med 165 (2005) 113-117
93. Arsura E.L., Kilgore W.B., and Ratnayake S.N. Erythema nodosum in pregnant patients with coccidioidomycosis. Clin Infect Dis 27 (1998) 1201-1203
94. Caldwell J.W., Arsura E.L., Kilgore W.B., Garcia A.L., Reddy V., and Johnson R.H. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet Gynecol 95 (2000) 236-239
95. Braverman I.M. Protective effects of erythema nodosum in coccidioidomycosis. Lancet 353 (1999) 168
96. Walker M.P., Brody C.Z., and Resnik R. Reactivation of coccidioidomycosis in pregnancy. Obstet Gynecol 79 (1992) 815-817
97. Peterson C.M., Schuppert K., Kelly P.C., and Pappagianis D. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 48 (1993) 149-156
98. Pappagianis D. Serologic studies in coccidioidomycosis. Semin Respir Infect 16 (2001) 242-250
99. Cox A., and Smith C. Arrested pulmonary coccidioidal granuloma. Arch Pathol 27 (1939) 717-734
100. Bouza E., Dreyer J.S., Hewitt W.L., and Meyer R.D. Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine 60 (1981) 139-172
101. Bried J.M., and Galgiani J.N. Coccidioides immitis infections in bones and joints. Clin Orthop 211 (1986) 235-243
102. Holley K., Muldoon M., and Tasker S. Coccidioides immitis osteomyelitis: a case series review. Orthopedics 25 (2002) 827-831 32
103. Cardone J.S., Vinson R., and Anderson L.L. Coccidioidomycosis: the other great imitator. Cutis 56 (1995) 33-36
104. Huntington Jr. R.W. Coccidioidomycosis-a great imitator disease. Arch Pathol Lab Med 110 (1986) 182
105. DiCaudo D.J., and Connolly S.M. Interstitial granulomatous dermatitis associated with pulmonary coccidioidomycosis. J Am Acad Dermatol 45 (2001) 840-845
106. Drutz D.J., and Catanzaro A. Coccidioidomycosis. Part II. Am Rev Respir Dis 117 (1978) 727-771
107. Smith C. Epidemiology of acute coccidioidomycosis with erythema nodosum ("San Joaquin" or "valley fever". Am J Public Health 30 (1940) 600-611
108. Psychos D.N., Voulgari P.V., Skopouli F.N., Drosos A.A., and Moutsopoulos H.M. Erythema nodosum: the underlying conditions. Clin Rheumatol 19 (2000) 212-216
109. Cribier B., Caille A., Heid E., and Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 37 (1998) 667-672
110. Richardson Jr. H.B., Anderson J.A., and McKay B.M. Acute pulmonary coccidioidomycosis in children. J Pediatr 70 (1967) 376-382
111. DiCaudo DJ, Yiannias JA, Laman SD, Warschaw KE. The exanthem of acute pulmonary coccidioidomycosis: clinical and histopathologic features of three cases and review of the literature. Arch Dermatol 2006;142:744-6.
112. Werner S.B. Coccidioidomycosis misdiagnosed as contact dermatitis. Calif Med 117 (1972) 59-61
113. Harvey W.C., and Greendyke W.H. Skin lesions in acute coccidioidomycosis. Am Fam Physician GP 2 (1970) 81-85
114. Ramras D.G., Walch H.A., Murray J.P., and Davidson B.H. An epidemic of coccidioidomycosis in the Pacific beach area of San Diego. Am Rev Respir Dis 101 (1970) 975-978
115. Huff J.C., Weston W.L., and Tonnesen M.G. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 8 (1983) 763-775
116. Moreno A.J., Weisman I., Kenney R.L., and Fort S.L. Concurrence of erythema multiforme and erythema nodosum. Cutis 31 (1983) 275-278
117. Brice S.L., Huff J.C., and Weston W.L. Erythema multiforme minor in children. Pediatrician 18 (1991) 188-194
118. Brice SL, Huff JC, Weston WL. Erythema multiforme. Curr Probl Dermatol 1990;Jan/Feb:2-25.
119. Sweet R.D. An acute febrile neutrophilic dermatosis. Br J Dermatol 76 (1964) 349-356
120. Sweet R.D. An acute febrile neutrophilic dermatosis-1978. Br J Dermatol 100 (1979) 93-99
121. Cohen P.R., and Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 42 (2003) 761-778
122. Burrall B. Sweet's syndrome (acute febrile neutrophilic dermatosis). Dermatol Online J 5 1 (1999) 8
123. Su W.P., Fett D.L., Gibson L.E., and Pittelkow M.R. Sweet syndrome: acute febrile neutrophilic dermatosis. Semin Dermatol 14 (1995) 173-178
124. Fett D.L., Gibson L.E., and Su W.P. Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 70 (1995) 234-240
125. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31 (1994) 535-556
126. Holemans X., Levecque P., Despontin K., and Maton J.P. Premiere association d'une coccidioidomycose et d'un syndrome de Sweet. Presse Med 29 (2000) 1282-1284
127. DiCaudo D.J., Ortiz K.J., Mengden S.J., and Lim K.K. Sweet syndrome (acute febrile neutrophilic dermatosis) associated with pulmonary coccidioidomycosis. Arch Dermatol 141 (2005) 881-884
128. Magro C.M., Crowson A.N., and Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol 27 (1996) 50-56
129. Hobbs E.R. Coccidioidomycosis. Dermatol Clin 7 (1989) 227-239
130. Schwartz R.A., and Lamberts R.J. Isolated nodular cutaneous coccidioidomycosis. The initial manifestation of disseminated disease. J Am Acad Dermatol 4 (1981) 38-46
131. Quimby S.R., Connolly S.M., Winkelmann R.K., and Smilack J.D. Clinicopathologic spectrum of specific cutaneous lesions of disseminated coccidioidomycosis. J Am Acad Dermatol 26 (1992) 79-85
132. Hobbs E.R., and Hempstead R.W. Cutaneous coccidioidomycosis simulating lepromatous leprosy. Int J Dermatol 23 (1984) 334-336
133. Arsura E.L., Kilgore W.B., Caldwell J.W., Freeman J.C., Einstein H.E., and Johnson R.H. Association between facial cutaneous coccidioidomycosis and meningitis. West J Med 169 (1998) 13-16
134. O'Brien J.J., and Gilsdorf J.R. Primary cutaneous coccidioidomycosis in childhood. Pediatr Infect Dis 5 (1986) 485-486
135. Winn W.A. Primary cutaneous coccidioidomycosis. Reevaluation of its potentiality based on study of three new cases. Arch Dermatol 92 (1965) 221-228
136. Levan N.E., and Huntington Jr. R.W. Primary cutaneous coccidioidomycosis in agricultural workers. Arch Dermatol 92 (1965) 215-220
137. Carroll G.F., Haley L.D., and Brown J.M. Primary cutaneous coccidioidomycosis: a review of the literature and a report of a new case. Arch Dermatol 113 (1977) 933-936
138. Bonifaz A., Saul A., Galindo J., and Andrade R. Primary cutaneous coccidioidomycosis treated with itraconazole. Int J Dermatol 33 (1994) 720-722
139. Trimble J., and Doucette J. Primary cutaneous coccidioidomycosis. Arch Dermatol 74 (1956) 405
140. Wilson J., Smith C., and Plunkett O. Primary cutaneous coccidioidomycosis: the criteria for diagnosis and report of a case. Calif Med 79 (1953) 233-239
141. Chang A., Tung R.C., McGillis T.S., Bergfeld W.F., and Taylor J.S. Primary cutaneous coccidioidomycosis. J Am Acad Dermatol 49 (2003) 944-949
142. Overholt E.L., and Hornick R.B. Primary cutaneous coccidioidomycosis. Arch Int Med 114 (1964) 149-153
143. Pappagianis D. The phenomenon of locus minoris resistentiae in coccidioidomycosis. In: Einstein H.E., and Catanzaro A. (Eds). Coccidioidomycosis (1985), National Foundation for Infectious Diseases, Washington, DC 319-329
144. Zartarian M., Peterson E.M., and de la Maza L.M. Detection of antibodies to Coccidioides immitis by enzyme immunoassay. Am J Clin Pathol 107 (1997) 148-153
145. Kaufman L., Sekhon A.S., Moledina N., Jalbert M., and Pappagianis D. Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol 33 (1995) 618-619
146. Galgiani J. Coccidioides immitis. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases Vol 2 (2000), Churchill Livingstone, Philadelphia 2746-2757
147. Huppert M., Sun S.H., and Rice E.H. Specificity of exoantigens for identifying cultures of Coccidioides immitis. J Clin Microbiol 8 (1978) 346-348
148. Padhye A.A., Smith G., Standard P.G., McLaughlin D., and Kaufman L. Comparative evaluation of chemiluminescent DNA probe assays and exoantigen tests for rapid identification of Blastomyces dermatitidis and Coccidioides immitis. J Clin Microbiol 32 (1994) 867-870
149. Sandhu G.S., Kline B.C., Stockman L., and Roberts G.D. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 33 (1995) 2913-2919
150. Hayden R.T., Qian X., Roberts G.D., and Lloyd R.V. In situ hybridization for the identification of yeastlike organisms in tissue section. Diagn Mol Pathol 10 (2001) 15-23
151. Bialek R., Kern J., Herrmann T., Tijerina R., Cecenas L., Reischl U., et al. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J Clin Microbiol 42 (2004) 778-783
152. Greendyke W.H., Resnick D.L., and Harvey W.C. The varied roentgen manifestations of primary coccidioidomycosis. Am J Roentgenol Radium Ther Nucl Med 109 (1970) 491-499
153. Batra P. Pulmonary coccidioidomycosis. J Thorac Imaging 7 (1992) 29-38
154. Batra P., and Batra R.S. Thoracic coccidioidomycosis. Semin Roentgenol 31 (1996) 28-44
155. McGahan J.P., Graves D.S., Palmer P.E., Stadalnik R.C., and Dublin A.B. Classic and contemporary imaging of coccidioidomycosis. Am J Roentgenol 136 (1981) 393-404
156. Shetter A.G., Fischer D.W., and Flom R.A. Computed tomography in cases of coccidioidal meningitis, with clinical correlation. West J Med 142 (1985) 782-786
157. Kim K.I., Leung A.N., Flint J.D., and Muller N.L. Chronic pulmonary coccidioidomycosis: computed tomographic and pathologic findings in 18 patients. Can Assoc Radiol J 49 (1998) 401-407
158. Cohen A.J., Braunstein P., and Pais M.J. The role of gallium and bone scintigraphy in disseminated coccidioidomycosis. Clin Nucl Med 9 (1984) 538-539
159. Zeppa M.A., Laorr A., Greenspan A., McGahan J.P., and Steinbach L.S. Skeletal coccidioidomycosis: imaging findings in 19 patients. Skeletal Radiol 25 (1996) 337-343
160. Galgiani J.N., Ampel N.M., Catanzaro A., Johnson R.H., Stevens D.A., and Williams P.L. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 30 (2000) 658-661
161. Deresinski SC. Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis 14 (2001) 693-696
162. Galgiani J.N., Ampel N.M., Blair J.E., Catanzaro A., Johnson R.H., Stevens D.A., et al. Coccidioidomycosis. Clin Infect Dis 41 (2005) 1217-1223
163. Ampel N.M. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis 41 (2005) 1174-1178
164. Blair J.E., Douglas D.D., and Mulligan D.C. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 5 (2003) 3-8
165. Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole). Mycoses 42 (1999) 83-86
166. Li R.K., Ciblak M.A., Nordoff N., Pasarell L., Warnock D.W., and McGinnis M.R. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 44 (2000) 1734-1736
167. Gonzalez G.M., Tijerina R., Najvar L.K., Bocanegra R., Rinaldi M., Loebenberg D., et al. In vitro and in vivo activities of posaconazole against Coccidioides immitis. Antimicrob Agents Chemother 46 (2002) 1352-1356
168. Gonzalez G.M., Tijerina R., Sutton D.A., Graybill J.R., and Rinaldi M.G. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. Antimicrob Agents Chemother 46 (2002) 1583-1585
169. Hsue G., Napier J.T., Prince R.A., Chi J., and Hospenthal D.R. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 54 (2004) 292-294
170. Proia L.A., and Tenorio A.R. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother 48 (2004) 2341
171. Clemons K.V., and Stevens D.A. Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. Antimicrob Agents Chemother 44 (2000) 1874-1877
172. Antony S., Dominguez D.C., and Sotelo E. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis. J Natl Med Assoc 95 (2003) 982-985
173. Koehler A.P., Cheng A.F., Chu K.C., Chan C.H., Ho A.S., and Lyon D.J. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. J Infect 36 (1998) 113-115
174. Pappagianis D. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. Fungal Genet Biol 32 (2001) 1-9
175. Delgado N., Xue J., Yu J.J., Hung C.Y., and Cole G.T. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect Immun 71 (2003) 3010-3019
176. Cole G.T., Xue J.M., Okeke C.N., Tarcha E.J., Basrur V., Schaller R.A., et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 42 (2004) 189-216
177. Jiang C., Magee D.M., Quitugua T.N., and Cox R.A. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA. Infect Immun 67 (1999) 630-635
178. Jiang C., Magee D.M., Ivey F.D., and Cox R.A. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis. Infect Immun 70 (2002) 3539-3545
179. Zimmermann C.R., Johnson S.M., Martens G.W., White A.G., Zimmer B.L., and Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun 66 (1998) 2342-2345
180. Kirkland T.N., Raz E., and Datta S.K. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. Vaccine 24 (2006) 495-500